Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Discover the pros and cons of long term versus short term investing. Make informed decisions based on your financial goals.
28,015 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
An overlooked defense contractor pivots to AI, turning years of skepticism into a rising star in enterprise AI and de...
Ford is aiming high with an AI-driven energy storage push. This article breaks down what that could mean for investor...
Leaders are navigating a three-way test: grow economies, protect energy security, and push for sustainability. This b...
A new poll finds a prevailing mood that founders would be disappointed by modern democracy. This sentiment is shaping...
You’ve hit the IRA max. Now what? This practical guide lays out clear steps, tax-smart options, and real-world scenar...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
Herald Investment Management disclosed a new 202,000-share position in DigitalOcean Holdings (DOCN), valued at roughl...
Uncover what historically cheap ultra-high-yield dividend opportunities look like, why prices swing, and how to build...
2025 delivered a record surge in corporate giving and volunteerism, signaling a durable pivot in corporate activism d...
Divorce becomes a high-stakes financial exercise when billions are on the line. This guide breaks down practical step...
SpaceX is rumored to target a June 12 IPO, igniting widespread speculation about a valuation that could dwarf most te...